Deficiency
Chromium Deficiency: What the Evidence Actually Shows
Chromium is an essential trace mineral with a plausible role in insulin function, but the clinical evidence for supplementation remains limited to insufficient across most health claims.

Chromium is a trace mineral that may play a supporting role in how the body responds to insulin, but robust clinical evidence for most supplement claims is still lacking. Here is what the current science actually shows, grounded in data from the NIH Office of Dietary Supplements (ODS).
What Chromium Does in the Body
According to the NIH ODS, chromium has several proposed physiological roles, though researchers continue to study the exact mechanisms involved.
- Insulin potentiation: Chromium may help potentiate the action of insulin, which is involved in carbohydrate, lipid, and protein metabolism.
- Chromodulin hypothesis: Chromium is proposed to form a molecule called chromodulin, which may help activate the insulin receptor. This mechanism is still under investigation.
- Antioxidant activity: Chromium may have antioxidant effects, though this area of research is early and not well characterized.
It is important to note that these are physiological roles and proposed mechanisms. Supplements are not intended to diagnose, treat, cure or prevent any disease and these statements have not been evaluated by the FDA.
How Much Chromium Do Adults Need?
The NIH ODS and the National Academies of Sciences, Engineering, and Medicine set intake reference values for chromium. Notably, these are Adequate Intakes (AIs), not Recommended Dietary Allowances (RDAs). An AI is used when there is not enough data to establish a firm RDA, meaning the target carries more uncertainty than an RDA would.
- Adult males (ages 19 to 50): 35 micrograms (mcg) per day
- Adult females (ages 19 to 50): 25 mcg per day
These figures come directly from the NIH ODS. Because chromium is found in a wide variety of foods, including whole grains, broccoli, grape juice, and meat, most people in the United States consume amounts in this range through their regular diet. True clinical chromium deficiency is considered rare in healthy individuals.
Is There a Safe Upper Limit?
The Food and Nutrition Board has not established a Tolerable Upper Intake Level (UL) for chromium. According to the NIH ODS, this is because no adverse effects have been convincingly linked to high chromium intake from food or supplements in the available evidence. However, the Board advised caution due to limited long-term data on high-dose supplementation.
Isolated case reports have described serious adverse effects associated with chromium supplement use, including liver dysfunction, renal failure, rhabdomyolysis, anemia, thrombocytopenia, dermatitis, and hypoglycemia. These reports do not establish causation, but they underscore the importance of not treating the absence of a UL as a green light for unlimited intake. Anyone with kidney or liver conditions should be especially cautious and should speak with a clinician before using chromium supplements.
What Does the Research Actually Show?
Below are the main areas where chromium supplementation has been studied, along with honest evidence grades that mirror the NIH ODS assessments.
Insulin Action and Metabolism (Moderate Evidence)
The strongest signal in the chromium literature is its potential to potentiate the action of insulin in carbohydrate, lipid, and protein metabolism. The NIH ODS grades this at a moderate evidence level, making it the best-supported claim associated with this mineral.
Type 2 Diabetes and Glycemic Control (Insufficient Evidence)
Several trials have examined whether chromium supplements improve blood sugar control in people with type 2 diabetes. The NIH ODS currently grades this evidence as insufficient. Study results have been inconsistent, methodologies vary widely, and many trials are small or poorly controlled. No conclusions about benefit can be drawn from the current body of research.
Metabolic Syndrome (Insufficient Evidence)
Research into chromium supplementation for metabolic syndrome is also graded as insufficient by the NIH ODS. There is not yet enough high-quality evidence to support a clinical recommendation in this area.
Polycystic Ovary Syndrome (Limited Evidence)
Some studies have looked at chromium supplementation in people with polycystic ovary syndrome (PCOS), particularly regarding insulin sensitivity and hormonal markers. The NIH ODS grades this as limited evidence, meaning early signals exist but the research base is not yet strong enough to draw firm conclusions.
Blood Lipids and Dyslipidemia (Insufficient Evidence)
The evidence that chromium supplements improve cholesterol or triglyceride levels is graded as insufficient by the NIH ODS. Trials have produced mixed results and do not yet support a clear clinical benefit.
Body Weight and Body Fat (Limited Evidence)
A number of studies have investigated whether chromium supplements reduce body weight or fat mass. The NIH ODS grades this as limited evidence. While some trials show modest effects, the overall picture is not consistent enough to support a strong conclusion.
Drug and Supplement Interactions to Know
Chromium can interact with several common medications. If you take any of the following, talk to your doctor or pharmacist before adding a chromium supplement.
- Insulin: Chromium might increase insulin sensitivity. Taking it alongside insulin could increase the risk of hypoglycemia (low blood sugar).
- Metformin and other antidiabetes medications: Chromium may have an additive glucose-lowering effect, which could also raise hypoglycemia risk.
- Levothyroxine: In a small study, taking chromium picolinate at the same time as levothyroxine decreased levothyroxine absorption over a six-hour period. People on thyroid medication should separate doses and consult their prescriber.
The Bottom Line
Chromium plays a plausible supporting role in insulin-related metabolism, and the NIH ODS considers that connection to have moderate evidence behind it. However, for most specific health applications, including blood sugar management in type 2 diabetes, lipid improvement, and weight loss, the evidence is currently rated limited to insufficient. The AI targets of 35 mcg per day for adult males and 25 mcg per day for adult females are achievable through a varied diet for most people. No upper intake limit has been set, but that does not mean high-dose supplementation is without risk. Please consult a clinician or pharmacist for personal dosing guidance, and always speak with your doctor before combining any supplement with prescription medication.
Sources: NIH Office of Dietary Supplements Chromium Fact Sheet for Health Professionals (ods.od.nih.gov), NIH ODS Chromium Consumer Fact Sheet, and the National Academies Dietary Reference Intakes report (nap.nationalacademies.org/catalog/10026).
Sources
- S1.gov verifiedNIH Office of Dietary Supplements (ODS)Chromium - Health Professional Fact Sheetods.od.nih.gov/factsheets/Chromium-HealthProfessiona
- S2.gov verifiedNIH Office of Dietary Supplements (ODS)Chromium - Consumer Fact Sheetods.od.nih.gov/factsheets/Chromium-Consumer/
- S3.gov verifiedInstitute of Medicine (NASEM), Food and Nutrition BoardDietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc (2001)nap.nationalacademies.org/catalog/10026